MBOT - Microbot Medical Inc. News

B. Riley Securities Reiterates Buy on Microbot Medical, Lowers Price Target to $4

B. Riley Securities analyst Anderson Schock reiterates Microbot Medical (NASDAQ:MBOT) with a Buy

Microbot Medical Inc. (MBOT) Reports Q2 Loss, Lags Revenue Estimates

Microbot Medical Inc. (MBOT) came out with a quarterly loss of $0.08 per share in line with the Zack

Microbot Medical Q2 EPS $(0.08), Inline, Sales $241.000K Miss $340.000K Estimate

Microbot Medical (NASDAQ:MBOT) reported quarterly losses of $(0.08) per share which met the analyst

Microbot Medical® Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second

Revenue increased by more than 100% over the prior fiscal quarter, driven by repeat orders, expanded

New Strong Buy Stocks for July 23rd

PLGO, BLPD, INN, RFIL and MBOT have been added to the Zacks Rank #1 (Strong Buy) List on July 23, 20

Microbot Medical® Among Featured Companies Showcasing Novel Robotic Technologies and Digital Surgery

HINGHAM, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer an

Microbot Medical Reports 100% Growth In Revenue, New Clients In Q2

Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascu

Microbot Medical® Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in th

The Company is experiencing rising demand and increasing pipeline for the LIBERTY System since comme

Microbot Medical Signs Letter With Manufacturer Sanmina To Produce Its LIBERTY Single-Use, Remotely

As momentum continues to rise in the U.S., reflected in increased accounts and usage across several

Microbot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters i

HINGHAM, Mass., June 30, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer an

Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System

HINGHAM, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer an

Microbot Medical® Announces First Health System in Pennsylvania to Adopt the LIBERTY® Endovascular R

Leading academic center with multi-hospital and multi-state health system deepens Company's footprin

Microbot Medical Inks Agreement With Lovell Government Services To Serve Federal Healthcare Systems

Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascu

Microbot Medical® Enters Into an Agreement to Expand Access for America's Veteran and Military Patie

HINGHAM, Mass., June 16, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer an

Microbot Medical® Announces a Notable Health System as the First in Michigan to Adopt the LIBERTY® E

HINGHAM, Mass., June 09, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer an

LUCID CAPITAL MARKETS Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target

LUCID CAPITAL MARKETS analyst Alex Nowark initiates coverage on Microbot Medical (NASDAQ:MBOT) wi

Microbot Medical® Secures the First Healthcare System in North Carolina to Adopt the LIBERTY® Endova

HINGHAM, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer an

Microbot Medical Receives Israel's Marketing Clearance For Its LIBERTY System

Microbot Medical Inc. (NASDAQ:MBOT), developer and distributor of the innovative LIBERTY® Endovascul

Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of

Israel becomes the second jurisdiction and the first outside of the U.S. to grant marketing clearanc

After Plunging 22.6% in 4 Weeks, Here's Why the Trend Might Reverse for Microbot Medical (MBOT)

Microbot Medical (MBOT) is technically in oversold territory now, so the heavy selling pressure migh

seekingalpha.com

Microbot Medical Inc. (MBOT) Shareholder/Analyst Call Transcript

Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive

Microbot to Hold Conference Call to Review Recent Progress; Executive Team to be Joined by Current L

Watching Microbot Medical; Shares See Volume To The Downside; White Diamond Research Issues Report O

https://whitediamondresearch.com/research/we-interviewed-some-of-the-first-surgeons-to-use-microbot-

Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting f

Recent transition to the Full Market Release has already resulted in increased revenue for the curre

Microbot Medical Inc. (MBOT) Reports Q1 Loss, Misses Revenue Estimates

Microbot Medical Inc. (MBOT) came out with a quarterly loss of $0.05 per share versus the Zacks Cons

Microbot Medical Announces LIBERTY System Gains Clinical Validation And Early Commercial Adoption As

Commercial adoption of the LIBERTY System by sites that participated in the clinical trial serves as

Microbot Medical®'s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across

Commercial adoption of the LIBERTY System by sites that participated in the clinical trial serves as

Microbot Medical® Announces the Addition of Senior Commercial Executive with Proven Track Record to

Commencement of activities in international markets is supported by the successful completion of the

Stryker to Report Q1 Earnings: What's in Store for the Stock?

SYK heads into Q1 earnings with strong procedure demand and robotic surgery growth, but tariff and c

HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Microbot Medical (NASDAQ:MBOT) with

Microbot Medical Completes Limited Market Release Of Its LIBERTY Endovascular Robotic System, With C

To date, LIBERTY has been adopted by multiple healthcare systems with dozens of hospitals in their n

Microbot Medical Q4 EPS $(0.04) Beats $(0.06) Estimate

Microbot Medical (NASDAQ:MBOT) reported quarterly losses of $(0.04) per share which beat the analyst

Emory Healthcare Announces Successful Use Of Microbot Medical's Liberty System In Robotic Peripheral

Emory interventional radiologists have now demonstrated successful use of the LIBERTY System on beni

Microbot Medical Commends American Medical Association's Expanding Efforts To Protect Health Care Pr

Microbot Medical Inc. (NASDAQ:MBOT), developer and distributor of the innovative LIBERTY® Endovascul

Tampa General Hospital Adopts Small-Cap Microbot Medical's Robotic System

Microbot Medical stock jumps after Tampa General adopts its FDA-cleared LIBERTY robotic system ahead

Microbot Medical Highlights LIBERTY Endovascular Robotic System At ISET Conference

International Symposium on Endovascular Therapy (ISET) Convened Key Opinion Leaders to Discuss Advan

Looking Into Microbot Medical Inc's Recent Short Interest

This Microbot Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Tues

B. Riley Securities Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target o

B. Riley Securities analyst Anderson Schock initiates coverage on Microbot Medical (NASDAQ:MBOT)

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Why Credo Technology Group Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarke

Microbot Medical Says It Enters 2026 With Market Momentum Following FDA 510(k) Clearance Of LIBERTY,

Limited Market Release (LMR) of the LIBERTY® System is on ScheduleBuilding on Positive Customer Feed

Roth Capital Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $5.5

Roth Capital analyst Kyle Bauser initiates coverage on Microbot Medical (NASDAQ:MBOT) with a Buy

HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Microbot Medical (NASDAQ:MBOT) with

Microbot Medical Says Emory University Hospital Adopts LIBERTY For Patient Care; Microbot Collaborat

Microbot Medical Inc. (NASDAQ:MBOT), developer and distributor of the innovative LIBERTY Endovascula

Microbot Medical Announces Commercial Availability Of LIBERTY Robotic System In U.S.

Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascu

Microbot Medical Announces It Will Exhibit Its Liberty Endovascular Robotic System At Symposium On C

Microbot Medical Inc. (NASDAQ:MBOT), developer and distributer of the innovative LIBERTY® Endovascul

HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Microbot Medical (NASDAQ:MBOT) with

Microbot Medical Partners With U.S. Based 3PL Company To Support Commercialization Of FDA-Cleared LI

The Experienced MedTech Logistics Provider Will Help Ensure Effective and Efficient Inventory Manage